Merck Case Analysis Essay - 605 Words

Stakeholder Analysis – Merck Identify Key Stakeholders In the pharmaceutical industry, there is much to consider and constantly change in order to continue profits. In order to continue profits, a main factor, as said by former Merck president George W Merck, is the people. Merck said, â€Å"We try to never forget that medicine is for the people†. The first group of stakeholders has to be the people, or the consumer. The consumer is actually using the product from Merck and Co. and ultimately determines the success of the business. The second group of stakeholders is the employees. Employees determine the performance of the company. The employees consist of the executives and the lower management. A third group is the research and†¦show more content†¦4,400 employees were laid of in 2006. When profitability of the company decreases, changes need to be made and employees do not want that change to be their position. Researchers and developers are interested that their product in successful for Me rck. They want to create a product that will help the consumer and the employees. The doctors are interested in a product that will benefit their patients. The pharmaceutical company the doctor uses needs to be trustworthy and reputable. If something goes wrong with what the doctor prescribed, the patients may eave the doctor. Lastly, the investors are interested in the success of the company because like I stated earlier, the investor wants a return on their investment. The investor is interested in how well the products sell and for what price they are selling and essentially wants to see profits. Identify and Discuss Specific Stakeholder Preferences The consumer would want Merck to invest in the safest and most beneficial product that will help their needs. The employees want to take the route that will better the company overall. If the company succeeds, they make more money and are ultimately more successful professionally and personally. The researchers and developers of the product want to take the route that creates new products because then they play a vital role in the creation process. Doctors will wants to see the safest and most efficient products on the market that will help the reputation of the doctor toShow MoreRelatedMerck/Medco Case Analysis Essay3123 Words   |  13 PagesCASE 5.1: MERCK ACQUISITION OF MEDCO Abstract          Corporate mergers and acquisitions (Mamp;A) have become popular across the globe during the last two decades due to globalization, liberalization, technological developments, and competitive business environment (Fisher amp; Siburg, 2009). The synergistic gains from Mamp;A may result from efficient management, economies of scale, profitable use of assets, exploitation of market power, and the use of complementary resources (MitchellRead MoreCase Analysis : The Case Of Dr. J. T, Merck, And Co.1535 Words   |  7 Pagesrisks and obstacles which includes country risk, culture risk, commercial risk and currency risk. Depending on the country a business is established, the risks vary in the type, occurrence and impact. Merck Sharp and Dohme Argentine, MSD, the subsidiary of a U.S based pharmaceutical company, Merck and Co., faced lots of such challenges. Antonio Mosquera faced a lot of country risks and obstacles. Country risk is the adverse effect on a company’s operations due the host country’s political, legalRead MoreMeck Executive Summary1599 Words   |  7 Pagespotential side effects relating to obesity. LAB approaches Merck amp; Co., Inc. (Merck) and asks the company to license Davanrik, as well as funding the clinical testing. Merck must decide whether or not to bid to license Davanrik and if so, at what price. Discussion Merck is facing patent expiration problem because most of its popular drugs are going to expire by 2002. Patent expiration will lead to a substantial loss of sales. Therefore, Merck must develop new compounds quickly to refresh its portfolioRead MoreEssay on Merck and Co., River Blindness1531 Words   |  7 PagesMerck and Co., River Blindness Ethical Case Analysis Lennard de Jong Excelsior College Author Note This paper was prepared for Business Ethics, Ethical Case Analysis, taught by Dr. Moser. Introduction and Situational Analysis The ethical dilemma in Merck and River Blindness is whether to pursue research that may or may result in profit, or to choose the safe option and go for profit rather than researching the drug. The drug could possibly lead to curing the deadly and detrimental diseaseRead MoreEssay about Case Memo: Merck Global Health and Access to Medicines604 Words   |  3 PagesCase Memo: Merck Global Health and Access to Medicines The topic, human rights responsibilities of the drug companies, which is always controversial, however, is almost sharply defined in a report by the UN Special Rapporteur on the right to health, submitted to the United Nations General Assembly in August 2008. 1 The ‘‘Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines’’ include responsibilities for transparency, management, monitoring and accountabilityRead MoreMerck Co1066 Words   |  5 PagesHow has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop a new drug? Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999, and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research, and (2) developing partnerships with smaller biotechnology companies. Since 1995, Merck had launchedRead MoreMedco606 Words   |  3 PagesCase Analysis – Merck Medco Merck was a pharmaceutical manufacturer while Medco Cost Containment Services was a pharmacy benefit manager (PBM). On November 18th, 1993, Merck purchased Medco for $6.6 billion. Immediately after this merger, Medco operated as a subsidiary of Merck. This acquisition of Medco by Merck is a clear example of Merck expanding its organizational boundaries while adding value to Mercks operations at the same time. The advantages of Merck Medco combining together are thatRead MoreUnderstanding Financial Reports Essay1394 Words   |  6 Pagesmodule 2 case study I am to do the following understanding financial reports and continue to review the financial statements of Merck and Novartis to learn additional information. The emphasis of this Case is to review the income statement, balance sheet and computation of ratios. Review the financial statements for the companies and answer the following questions for the last reporting year: Balance Sheet †¢ What components of stockholders equity does each of the companies disclose? o Merck CompanyRead MoreMerck Swot Analysis1571 Words   |  7 PagesMerck SWOT Analysis MGT/521 July 25, 2012 Merck SWOT Analysis Company Overview Merck is the 2nd largest pharmaceutical company in world offering prescription medications, biologics, vaccines, animal health, and consumer care products. It generated 48 billion dollars in revenue in 2011 and has 40,000 employees. Research and development of proprietary medicines for global marketing is the core of the business. Recent acquisitions and transactions designed to take advantageRead MoreCase Analysis : Big Pharma1067 Words   |  5 PagesEthics in Big Pharma Introduction In 2004, Merck Pharmaceuticals underwent difficult times as the U.S Senate investigate the unethical practices of the company in distributing their once highly profitable pain relieving drug, Vioxx. From the investigation, the infamous CEO, Raymond Gilmartin â€Å"involuntarily† resigned after public documentation in relation to Vioxx was released, (Lyon and Ulmer, p. 355-356). Along with Gilmartin resignation, the company fiscal future was damaged as the $90 per share